Successful immune tolerance in two children with severe haemophilia A
The Journal of Haemophilia Practice · 2013
DOI: 10.17225/jhp.00003 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Haemophilia Practice, 2013. Verfasst von Bert Leenders. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Haemophilia A is an X-linked congenital bleeding disorder resulting from a deficiency of factor VIII (FVIII). Therapy to prevent or treat bleeding is by replacement of the missing FVIII. However, as a consequence of treatment, patients with HA may develop inhibitory IgG antibodies to FVIII, termed “inhibitors”. When this occurs, treatment becomes more complex and costly and morbidity increases. Inhibitor formation, occurring in up to 36% of patients with severe HA, is currently one of the most significant complications affecting patients with HA [1,2]. In these two case studies, the management of bleeds in patients with inhibitors, and the long-term inhibitor eradication will be discussed.
Zitieren
APA
Leenders, B. (2013). Successful immune tolerance in two children with severe haemophilia A. The Journal of Haemophilia Practice. https://doi.org/10.17225/jhp.00003
Vancouver
Leenders B. Successful immune tolerance in two children with severe haemophilia A. The Journal of Haemophilia Practice. 2013. doi:10.17225/jhp.00003
BibTeX
@article{Leenders2013,
author = {Leenders, Bert},
title = {Successful immune tolerance in two children with severe haemophilia A},
journal = {The Journal of Haemophilia Practice},
year = {2013},
doi = {10.17225/jhp.00003}
}
EUVIMED